Yamaha Motor - Medical Device Business Division’s Post

The future of #labelfree biomolecular analysis is here. Drop by booth 3033 at #SLAS2025 to see it in action. #SLAS2025, #labelfree, #Alto, #DigitalSPR, #highthroughput, #userfriendly, #dataconnectivity, #labautomation

"We are delighted to invite you to UKEV 2024 in Newcastle. Zoey Wang will present her research, 'High-Efficiency Isolation of Exosomes by EXODUS H-600.' For more details, visit: https://lnkd.in/gdKdmGNs #EXODUSBIO #UKEV2024 #ExtracellularVesicles #EVResearch #ExosomeIsolation #EVsIsolation"

What effect does Polyethylene glycol (PEG) have on cells' weight, and mechanical and morphological properties?

What if you could use light to monitor blood pressure, or even track the progress of diseases like cancer? 💡 Boston University’s Darren Roblyer is at the forefront of a new area of engineering that uses optical technologies to track biological processes. As part of The Brink’s “Terriers Explain Stuff” series, student Natalie Lett (Boston University College of Communication’27) pays a visit to Roblyer’s lab for a full demo and explanation of this emerging tech, which has the potential to revolutionize healthcare. Learn more ➡️ http://spr.ly/6044Q4XEp

We are thrilled to drive business growth and innovation in Northern Ireland by applying deep technologies to industry challenges as part of the Smart Nano NI Technology Access Programme. Eleven companies will gain access to state-of-the-art facilities, expert mentoring, and collaboration opportunities, helping participants unlock new opportunities. 🚀 Emmanuel Tchombe, founder of participating company Falcon Tag, shares: 💥 “By leveraging the expertise and network offered, we aim to transform our prototype into a market-ready product that solves critical operational challenges across industries.” Learn more here ➡️ https://lnkd.in/dUqH3ZEW #Photonics #FutureNetworks #Innovation DigitalBio Systems, Falcon Tag, Finnebrogue, Flax & Teal Limited, Helix8, , KAIoptix, Kolayam, Movetru®, Sanyx, Sensor IT, We Bottle.

Witness the Next Generation of Multiomics What if one platform could streamline your research, cut costs, and accelerate your discoveries? At Beyond, we’re unveiling the future of Multiomics with two groundbreaking technologies—Trinity™, a revolutionary workflow for target capture, and AVITI24™, our advanced sequencing system that can replace multiple platforms and workflows—bringing you greater flexibility, affordability, and precision.

🌟Q-PLAN INTERNATIONAL successfully hosted a workshop at Graphene Week 2024 on behalf of the 2D-BioPAD project, alongside MUNASET, focusing on advancing #2Dmaterials for #biomedical applications. 🔬 👤 Experts and industry leaders gathered to discuss critical topics such as bioengineering, biosensing, and antimicrobial resistance. Our project, 2D-BioPAD, is developing an innovative platform to detect Alzheimer’s disease early using #graphene sensors, #aptamers, #nanoparticles, #microfluidics, and AI.💡 👏 Congratulations to our Q-PLAN team, Apostolos Tsolakis and Alexandra Gkouma, who supported and attended this insightful workshop! 📚 Read more here: https://lnkd.in/d9Jc8Qbw

🔍 The future of cell line development is here! Discover how we're contributing to advancements in biotherapeutics with a featured article on IPT Online, written by Maryam Ahmadi. "Advancing Cell Line Development: How Next-Gen Innovation Meets Industry Challenges" explores the revolutionary capabilities of platforms like Cyto-Mine® in overcoming challenges and accelerating research. 📖 Read the article now: https://bit.ly/3ZvhOa5 #SphereFluidics #CellLineDevelopment

SFNano - what a blast! 🚀 We had a fantastic time in Toulouse, sharing how the qEV Isolation platform and the Exoid can support researchers in nanomedicine! If this is something you're interested in, have a read of our recent article: https://hubs.la/Q02_mvtj0

Last week's meeting at the Rotterdam Science Tower was a landmark event for Delta Diagnostics and our partners. The purpose of this gathering was clear: to explore the innovative potential of our label-free biosensing technology and to strengthen our commitment to making this technology widely accessible. We are driven by a mission to democratize biosensing technology, ensuring that researchers from institutions of any size and funding level can benefit from our advanced solutions. Our photonic integrated circuit-based biosensors represent a leap forward, offering high-throughput, multiplexed, and label-free detection capabilities. This technology stands to change the way researchers approach biosensing, making complex analyses simpler, faster, and more cost-effective. Our distributor partners joined from across Europe, each bringing their unique perspective and expertise to the table. Claus Dall Larsen from LABLAB Aps (Denmark), Peter Blom of XboXLab AS (Sweden/Norway/Finland), Urs Wegmann and Malika Mühlebach from LABFORCE (Switzerland), and Josef Uskoba from iBiotech (Czech Republic/Hungary/Slovakia) all shared their insights on how we can better support them and tap into the opportunities presented by our biosensing technology. The discussions focused on collaborative strategies to enhance distributor support and to navigate the challenges of bringing sour tech to scientists. Our collective vision, "Enabling More For Less," highlights our commitment to breaking down the barriers to advanced biosensing tools, ensuring that these innovations are accessible to all researchers. It was a greatr step forward in a shared journey towards transforming biosensing technology and ensuring that every researcher has the opportunity to explore and discover without limitations. #photonics #biosensing #lifesciences